Best Agrolife Q1 FY27 earnings call

Best Agrolife Limited delivered a resilient performance in Q1 FY27, with revenue from operations increasing 4% year-on-year to ₹396 crores. Profitability saw significant improvement, with EBITDA growing 70% year-on-year to ₹78 crores, and EBITDA margins expanding to 20% from 12% in Q1 FY26. PAT more than doubled, increasing 104% year-on-year to ₹41 crores, with PAT margins reaching 10% from 5% in the prior year. This strong performance was attributed to a favorable product mix, disciplined pricing, and operational efficiency.

The company continued its strategic shift towards higher-margin patented products, increasing their contribution to branded sales to 64% in Q1 FY27, up from 45% in Q1 FY26. This focus led to a 37% increase in patented product volumes and a 13% increase in overall branded sales volumes to dealers. Management indicated that the patent portfolio's contribution is expected to remain between 60-70% of total branded sales, driving sustainable margin expansion. Products like BEST MAN, Fetagen, Warden Extra, Ronfen, and Tricolor performed well across key crop segments.

Q1 FY27 began with apprehension regarding monsoons, with early indications of 2026 and 2027 being a super El Niño year, potentially leading to extreme weather. Delayed monsoons and irregular rainfall, coupled with above-normal temperatures, impacted sowing and agriculture, leading to subdued demand and delayed planting. However, the situation improved towards the end of the quarter, with cumulative rainfall deviation from long-term average at around 113% and central regions showing only a 1% deficit. The company is cautiously optimistic^💬 about the rabi season and expects demand to improve as crops move into vegetative and reproductive cycles.

The improvement in profitability was also a result of enhanced operational efficiency and disciplined cost management. The company successfully passed on higher raw material costs through selective price increases in April and May. Inventories were reduced by approximately 6% year-on-year to ₹764 crores as of June 30, demonstrating a focus on inventory optimization and efficient capital utilization. Operating expenses, including finance costs and depreciation, increased only 4.5% year-on-year to ₹92.97 crores, reflecting continued cost optimization while supporting growth initiatives.

Best Agrolife Limited continues to progress in international markets, securing successful product registrations in Nepal, Thailand, Vietnam, and Mexico. Regulatory approval for patented products has also been fast-tracked in Sri Lanka. This expansion is part of the company's strategy to diversify its revenue streams and leverage its differentiated product portfolio globally.

CAPEX plans are currently on hold as the company prioritizes strengthening its existing business and improving profitability. Management indicated that they would revisit CAPEX once the business is on a 'steady wicket'. Regarding funding, a previous QIP was not converted as investors did not subscribe due to lower share prices. Discussions are ongoing with investors about future funding options. Working capital management has significantly improved, with inventories reduced by ₹300 crores over two years and advanced collections at better levels, making the working capital position stable.

Looking ahead, the company aims for a sustainable EBITDA margin of 13-14% under normal circumstances, driven by its differentiated product portfolio. Management expects a revenue CAGR of 10-15% each year. While Q1 and Q2 are typically stronger due to seasonality, the company has made a provision of ₹60 crores for 20% expected sales returns to mitigate volatility in Q3 and Q4, aiming for more stable performance throughout the year.